Literature DB >> 26172924

Irisin plasma concentration in PCOS and healthy subjects is related to body fat content and android fat distribution.

Katarzyna Pukajło1, Łukasz Łaczmański1, Katarzyna Kolackov1, Justyna Kuliczkowska-Płaksej1, Marek Bolanowski1, Andrzej Milewicz1, Jacek Daroszewski1.   

Abstract

Irisin (Ir), a recently identified adipo-myokine, cleaved and secreted from the protein FNDC5 in response to physical activity, has been postulated to induce the differentiation of a subset of white adipocytes into brown fat and to mediate the beneficial effects on metabolic homeostasis. Metabolic syndrome (MS), a cluster of factors leading to impaired energy homeostasis, affects a significant proportion of subjects suffering from polycystic ovary syndrome (PCOS). The aim of our study was to investigate the relationship between Ir plasma concentrations and metabolic disturbances. The study group consisted of 179 PCOS patients and a population of 122 healthy controls (both groups aged 25-35 years). A subset of 90 subjects with MS was isolated. A positive association between Ir plasma level and MS in the whole group and in controls was found. In subjects with high adipose body content (>40%), Ir was higher than in lean persons (<30%). Our results showed a significant positive association between Ir concentration and android type of adipose tissue in the whole study group and in the control group. Understanding the role of Ir in increased energy expenditure may lead to the development of new therapeutics for obesity and obesity-related diseases.

Entities:  

Keywords:  Android obesity; Irisin; metabolic syndrome; polycystic ovary syndrome

Mesh:

Substances:

Year:  2015        PMID: 26172924     DOI: 10.3109/09513590.2015.1065482

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  10 in total

Review 1.  Irisin in metabolic diseases.

Authors:  Stergios A Polyzos; Athanasios D Anastasilakis; Zoe A Efstathiadou; Polyzois Makras; Nikolaos Perakakis; Jannis Kountouras; Christos S Mantzoros
Journal:  Endocrine       Date:  2017-11-23       Impact factor: 3.633

2.  Fibronectin type III domain-containing 5 in cardiovascular and metabolic diseases: a promising biomarker and therapeutic target.

Authors:  Xin Zhang; Can Hu; Hai-Ming Wu; Zhen-Guo Ma; Qi-Zhu Tang
Journal:  Acta Pharmacol Sin       Date:  2020-11-19       Impact factor: 7.169

3.  Effects of running a marathon on irisin concentration in men aged over 50.

Authors:  Paweł Jóźków; Dawid Koźlenia; Katarzyna Zawadzka; Marek Konefał; Paweł Chmura; Katarzyna Młynarska; Michał Kosowski; Marek Mędraś; Jan Chmura; Piotr Ponikowski; Jacek Daroszewski
Journal:  J Physiol Sci       Date:  2018-05-14       Impact factor: 2.781

4.  Irisin as a Novel Marker for Insulin Resistance in Iraqi Women with Polycystic Ovary Syndrome Before and After Metformin Therapy.

Authors:  Fatin Shallal Farhan; Shatha Sami Hussien
Journal:  J Obstet Gynaecol India       Date:  2018-09-15

5.  The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients.

Authors:  Chia Lin Chang; Shang Yu Huang; Ya Chiung Hsu; Tzu Hsuan Chin; Yung Kuei Soong
Journal:  Sci Rep       Date:  2019-04-23       Impact factor: 4.379

6.  A Randomized-Controlled Trial Pilot Study Examining the Effect of Pelvic Floor Muscle Training on the Irisin Concentration in Overweight or Obese Elderly Women with Stress Urinary Incontinence.

Authors:  Magdalena Weber-Rajek; Agnieszka Radzimińska; Agnieszka Strączyńska; Katarzyna Strojek; Zuzanna Piekorz; Mariusz Kozakiewicz; Hanna Styczyńska
Journal:  Biomed Res Int       Date:  2019-08-19       Impact factor: 3.411

7.  Irisin deletion induces a decrease in growth and fertility in mice.

Authors:  Yunyao Luo; Xiaoyong Qiao; Yaxian Ma; Hongxia Deng; Charles C Xu; Liangzhi Xu
Journal:  Reprod Biol Endocrinol       Date:  2021-02-13       Impact factor: 5.211

8.  Thermogenic adipocytes: lineage, function and therapeutic potential.

Authors:  Alice E Pollard; David Carling
Journal:  Biochem J       Date:  2020-06-12       Impact factor: 3.857

Review 9.  Irisin: circulating levels in serum and its relation to gonadal axis.

Authors:  Yunyao Luo; Xiaoyong Qiao; Liangzhi Xu; Guoning Huang
Journal:  Endocrine       Date:  2022-01-17       Impact factor: 3.633

10.  Serum Irisin Levels and its Association with Blood Glucose and Insulin Indices in Diagnosing Insulin Resistance in Adolescents with Polycystic Ovarian Syndrome.

Authors:  Bhawina Sharan; Haritha Sagili; Sadish Kumar Kamalanathan; Subitha Lakshminarayanan
Journal:  J Hum Reprod Sci       Date:  2021-06-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.